Clinical Trials List
Protocol NumberHBP-01-01
Not yet recruiting
2007-03-01 - 2007-12-31
Phase IV
Terminated3
-
Trial Applicant
和聯藥業股份有限公司
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Hsien-Kun Chang Division of Hematology & Oncology
- Hung-Ming Wang Division of Hematology & Oncology
- 陳秉聰 Division of Hematology & Oncology
- Cheng-Lung Hsu Division of Hematology & Oncology
- Wen-Cheng Chang Division of Hematology & Oncology
- Jen-Shi Chen Division of Hematology & Oncology
- Tsai-Sheng Yang Division of Hematology & Oncology
- Yung-Chang Lin Division of Hematology & Oncology
- Chi-Ting Liau Division of Hematology & Oncology
- 廖宗琦 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 陳博明 Division of Hematology & Oncology
- Chueh-Chuan Yen Division of Hematology & Oncology
- Jyh-Pyng Gau Division of Hematology & Oncology
- Tzeon-jye Chiou Division of Hematology & Oncology
- 徐會棋 Division of Hematology & Oncology
- Jin-Hwang Liu Division of Hematology & Oncology
- Muh-Hwa Yang Division of Hematology & Oncology
- Liang-Tsai Hsiao Division of Hematology & Oncology
- 王緯書 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- James Chih-Hsin Yang Division of Hematology & Oncology
- 林璟宏 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
45 participants
-
Global
0 participants
